Cipla Limited (LUX: CIPLA)

Market Cap	13.30B
Revenue (ttm)	2.81B
Net Income (ttm)	478.90M
Shares Out	n/a
EPS (ttm)	0.59
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Aug 1, 2024

Volume	n/a
Open	n/a
Previous Close	17.90
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About Cipla

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormaliti...

• Industry: Pharmaceutical Preparations
• Founded: 1935
• Employees: 27,764
• Stock Exchange: Luxembourg Stock Exchange
• Ticker Symbol: CIPLA

Financial Performance

In 2023, Cipla's revenue was 255.37 billion, an increase of 13.20% compared to the previous year's 225.59 billion. Earnings were 41.22 billion, an increase of 47.10%.

Financial numbers in INR